Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer - Concepedia

Concepedia

Publication | Open Access

Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer

DOI Full Paper Access

11

Citations

42

References

2023

Year

Canan Karan, Arzu Yaren, Burçin Çakan Demirel, TOLGA DOGAN, Melek Özdemir, Atike Gökçen Demiray, Burcu Yapar Taşköylü, Serkan Değirmencioğlu, Gamze Gököz Doğu, Umut Çakıroğlu

Cancer Diagnosis & Prognosis

Abstract

PLR, C-reactive protein-to-albumin ratio, and serum LDH levels, but not NLR and LMR, may function as independent predictors in patients with advanced BC prior to systemic treatment.

References

	Year	Citations
Cancer statistics, 2023 Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle, CA A Cancer Journal for Clinicians Epidemiology Of CancerGynecologyCancer RegistrationCervical Cancer IncidenceUnited States	2023	16.1K
The Eighth Edition <scp>AJCC</scp> Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging Mahul B. Amin, Frederick L. Greene, Stephen B. Edge, CA A Cancer Journal for Clinicians Surgical OncologyCancer PathologyCancer ManagementPrognosisPathology	2017	6.3K
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines J. Alfred Witjes, Éva Compérat, Nigel C. Cowan, European Urology UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2013	1K
Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar, Journal of Clinical Oncology	1999	726
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma Matthew D. Galsky, G. J. Chen, William Oh, Annals of Oncology Comparative EffectivenessCarboplatin-based ChemotherapyUrologyOncologyGenitourinary Cancer	2011	289
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022 Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Journal of the National Comprehensive Cancer Network	2022	289
Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy Tatsuo Gondo, Jun Nakashima, Yoshio Ohno, Urology Radical CystectomySurgical OncologyUrologyGenitourinary CancerMedicine	2012	227
Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy Nancy L. Geller, Cora N. Sternberg, Darryl Penenberg, Cancer Prognostic FactorsSurgical OncologyUrologyGenitourinary CancerMedicine	1991	142
Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non–muscle-invasive bladder cancer Roy Mano, Jack Baniel, Ohad Shoshany, Urologic Oncology Seminars and Original Investigations UrologyCancer ImmunosurveillanceGenitourinary CancerMedicinePathology	2014	110
Preoperative and postoperative cytokines in patients with cancer Haruhiro Nakazaki Cancer	1992	109

Page 1